A Cost-Per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata

    June 2026 in “ Journal of health economics and outcomes research ”
    Ashley Cha-Silva, Kate Zhang, Christopher Graham … Eingun Song
    Studysummary This study found that ritlecitinib 50 mg offered a lower cost per responder than baricitinib 2 or 4 mg for treating severe alopecia areata at Weeks 24 and 52, potentially influencing reimbursement decisions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jheor.org →
    Discuss this study in the Community →

    Research cited in this study 11

    1. Systematic Review and Indirect Treatment Comparisons of Ritlecitinib Against Baricitinib in Alopecia Areata Journal of the European Academy of Dermatology and Venereology · 2024
    2. Expecting Scalp Hair Regrowth During Severe Alopecia Areata Treatment with Baricitinib: Insights from Patient Trajectories in Phase III Trials British Journal of Dermatology · 2023
    3. Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: A Randomised, Double-Blind, Multicentre, Phase 2b–3 Trial The Lancet · 2023
    4. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata Over 52 Weeks in Phase III Trials American Journal of Clinical Dermatology · 2023
    5. Healthcare Utilization And Costs Among US Adolescents With Alopecia Areata Journal of health economics and outcomes research · 2022
    6. Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA Dermatology and therapy · 2022
    7. The Epidemiology of Alopecia Areata: A Population-Based Cohort Study in UK Primary Care British Journal of Dermatology · 2021
    8. A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States Clinical Cosmetic and Investigational Dermatology · 2020
    9. Treatment of Alopecia Areata: An Australian Expert Consensus Statement Australasian journal of dermatology · 2018
    10. Health-Related Quality of Life Among Patients With Alopecia Areata: A Systematic Review Journal of The American Academy of Dermatology · 2016
    11. The Autoimmune Basis of Alopecia Areata: A Comprehensive Review Autoimmunity reviews · 2014